Theodore A. Vandenberg

1.5k total citations
26 papers, 774 citations indexed

About

Theodore A. Vandenberg is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Theodore A. Vandenberg has authored 26 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 8 papers in Genetics and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Theodore A. Vandenberg's work include Cancer Treatment and Pharmacology (10 papers), Estrogen and related hormone effects (7 papers) and HER2/EGFR in Cancer Research (7 papers). Theodore A. Vandenberg is often cited by papers focused on Cancer Treatment and Pharmacology (10 papers), Estrogen and related hormone effects (7 papers) and HER2/EGFR in Cancer Research (7 papers). Theodore A. Vandenberg collaborates with scholars based in Canada, United States and Australia. Theodore A. Vandenberg's co-authors include Ann F. Chambers, Francisco Perera, Alan B. Tuck, Katia Tonkin, Gordon S. Doig, Anna Tomiak, Sylvia M. Wilson, Vivien Bramwell, B. Norris and A. Muldal and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Theodore A. Vandenberg

25 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Theodore A. Vandenberg Canada	12	463	206	161	116	113	26	774
David Ransom Australia	18	524 1.1×	583 2.8×	220 1.4×	31 0.3×	120 1.1×	36	1.3k
Deanna McLeod Canada	15	461 1.0×	222 1.1×	224 1.4×	61 0.5×	30 0.3×	26	793
Damon Disch United States	10	544 1.2×	235 1.1×	191 1.2×	122 1.1×	456 4.0×	17	1.1k
S. J. Harland United Kingdom	18	390 0.8×	398 1.9×	72 0.4×	126 1.1×	135 1.2×	32	1.1k
Mareyuki Endoh Japan	18	187 0.4×	306 1.5×	158 1.0×	39 0.3×	78 0.7×	33	786
Masayuki Egawa Japan	14	186 0.4×	326 1.6×	104 0.6×	71 0.6×	172 1.5×	30	794
Hidekatsu Nakai Japan	21	445 1.0×	323 1.6×	194 1.2×	22 0.2×	80 0.7×	75	1.3k
B D Evans New Zealand	11	362 0.8×	217 1.1×	107 0.7×	74 0.6×	17 0.2×	24	728
Z Estrov United States	15	287 0.6×	335 1.6×	112 0.7×	129 1.1×	58 0.5×	17	1.1k
Corinna Wittmer Germany	18	192 0.4×	392 1.9×	193 1.2×	128 1.1×	35 0.3×	28	984

Countries citing papers authored by Theodore A. Vandenberg

Since Specialization

Citations

This map shows the geographic impact of Theodore A. Vandenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodore A. Vandenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodore A. Vandenberg more than expected).

Fields of papers citing papers by Theodore A. Vandenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theodore A. Vandenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodore A. Vandenberg. The network helps show where Theodore A. Vandenberg may publish in the future.

Co-authorship network of co-authors of Theodore A. Vandenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Theodore A. Vandenberg. A scholar is included among the top collaborators of Theodore A. Vandenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theodore A. Vandenberg. Theodore A. Vandenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doyle, C. T., Theodore A. Vandenberg, Cristiano Ferrario, et al.. (2020). 326P Exploratory analysis of TreatER+ight: A Canadian prospective real-world observational study in HR+ advanced breast cancer. Annals of Oncology. 31. S374–S375. 1 indexed citations

Borrie, Adrienne E., Yun‐Hee Choi, Francisco Perera, et al.. (2020). Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients. Breast Cancer Research and Treatment. 183(2). 365–372. 11 indexed citations

Raphael, Jacques, Alison L. Allan, Joelle Helou, et al.. (2020). Everolimus in Advanced Breast Cancer: A Systematic Review and Meta-analysis. Targeted Oncology. 15(6). 723–732. 11 indexed citations

Blanchette, Phillip, Melody Lam, Lucie Richard, et al.. (2020). Dementia risk among post-menopausal women treated with endocrine therapy for early-stage breast cancer in Ontario, Canada.. Journal of Clinical Oncology. 38(15_suppl). 521–521. 1 indexed citations

Borrie, Adrienne E., Yun‐Hee Choi, Francisco Perera, et al.. (2018). Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer. Breast Cancer Research and Treatment. 172(2). 371–379. 11 indexed citations

Brackstone, Muriel, David A. Palma, Alan B. Tuck, et al.. (2017). Concurrent Neoadjuvant Chemotherapy and Radiation Therapy in Locally Advanced Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(4). 769–776. 43 indexed citations

Lohmann, Ana Elisa, Judy-Anne W. Chapman, Margot J. Burnell, et al.. (2015). Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer. Breast Cancer Research and Treatment. 150(3). 605–611. 15 indexed citations

Parulekar, Wendy R., Samuel Aparício, Judy‐Anne W. Chapman, et al.. (2014). Lapatinib or trastuzumab with taxane therapy as first-line treatment in metastatic breast cancer (MBC): A biomarker analysis in NCIC CTG MA.31.. Journal of Clinical Oncology. 32(15_suppl). 601–601.

Vandenberg, Theodore A., et al.. (2013). Weakly Hormone Receptor–Positive Breast Cancer and Use of Adjuvant Hormonal Therapy. Current Oncology. 20(6). 612–613. 6 indexed citations

10.

Teft, Wendy A., Inna Y. Gong, B. Dingle, et al.. (2013). CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy. Breast Cancer Research and Treatment. 139(1). 95–105. 62 indexed citations

11.

Ginsburg, Ophira, Timothy P. Hanna, Theodore A. Vandenberg, et al.. (2012). The global cancer epidemic: opportunities for Canada in low- and middle-income countries. Canadian Medical Association Journal. 184(15). 1699–1704. 10 indexed citations

12.

Rodenhiser, David I., Joseph Andrews, Theodore A. Vandenberg, & Ann F. Chambers. (2011). Gene signatures of breast cancer progression and metastasis. Breast Cancer Research. 13(1). 201–201. 39 indexed citations

13.

Vandenberg, Theodore A., N. Coakley, C. DeGrasse, et al.. (2009). A Framework for the Organization and Delivery of Systemic Treatment. Current Oncology. 16(1). 4–15. 16 indexed citations

14.

Bramwell, Vivien, Gordon S. Doig, Alan B. Tuck, et al.. (2008). Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer. Breast Cancer Research and Treatment. 114(3). 503–511. 41 indexed citations

15.

Leighl, Natasha B., Susan Dent, Mark Clemons, et al.. (2007). A Phase 2 study of perifosine in advanced or metastatic breast cancer. Breast Cancer Research and Treatment. 108(1). 87–92. 60 indexed citations

16.

Younus, Jawaid & Theodore A. Vandenberg. (2005). A practical overview of aromatase inhibitors in postmenopausal women with hormone receptor-positive breast cancer.. PubMed. 92(4). E39–44. 2 indexed citations

17.

Younus, Jawaid & Theodore A. Vandenberg. (2005). A practical overview of aromatase inhibitors.. PubMed. 25(3c). 2497–502. 2 indexed citations

18.

Eisenhauer, Elizabeth A., F Letendre, W. Lofters, et al.. (1996). Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group.. Journal of Clinical Oncology. 14(2). 422–428. 137 indexed citations

19.

Vandenberg, Theodore A.. (1994). New developments in chemotherapy for metastatic breast cancer. Anti-Cancer Drugs. 5(3). 251–259. 4 indexed citations

20.

Vandenberg, Theodore A., K. Pritchard, E. Eisenhauer, et al.. (1993). Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study.. Journal of Clinical Oncology. 11(7). 1241–1244. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact